Antiarrhythmic properties of Dimebon-Reference-Cited by-同舟云学术

Antiarrhythmic properties of Dimebon

Published:1995-04 Issue:4 Volume:119 Page:362-364
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Galenko-Yaroshevskii P. A.,Chekanova O. A.,Skibitskii V. V.,Bartashevich V. V.,Khankoeva A. I.,Polyashova T. I.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02445893.pdf

Reference16 articles.

1. E. M. Ammar and A. N. Kudrin,Farmakol. Toksikol.,32, N o 5, 566–570 (1969).

2. M. L. Belen'kii,Quantifying Pharmacological Effects: Selected Topics [in Russian], Leningrad (1963).

3. A. I. Bryskin, I. K. Sokolov, E. E. Belen'kii, and N. G. Glazova,Farmakol. Toksikol.,37, N o 3, 303–306 (1974).

4. A. K. Grenader,Antiarrhythmics as Blockers of Ion Channels. Mechanisms of Action and Structure [in Russian], Pushchino (1987).

5. T. I. Il'yuchenok and I. A. Matveeva,Dimebon: a New Antihistamine, in:Ekspress-informatsiya. Novye Lekarstvennye Preparaty [Up-to-Date Information. New Drugs], N o 4, 12–16 (1989).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. X-ray mapping in heterocyclic design: 17. Crystal and molecular structures of the “molecule of the month”; and its hydrogenated form;Crystallography Reports;2011-01

2. Stereoselective reduction of the active substance of the medicinal preparation dimeb n to the corresponding cis- and trans-1,2,3,4,4a,9b-hexahydro derivatives;Chemistry of Heterocyclic Compounds;2011-01

3. γ-Carbolines and their hydrogenated derivatives 3.* Hydrogenated derivatives of γ-carbolines: chemical and biological poperties (Review);Chemistry of Heterocyclic Compounds;2011-01

4. From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™;Current Alzheimer Research;2010-03-01

5. Comparative characteristics of antiarrhythmic activity of phencarol and dimebone in neurogenic ventricular fibrillation;Bulletin of Experimental Biology and Medicine;1997-07